Previous close | 1.4000 |
Open | 1.5500 |
Bid | 0.0000 |
Ask | 0.0000 |
Strike | 20.00 |
Expiry date | 2025-01-17 |
Day's range | 1.3500 - 1.5500 |
Contract range | N/A |
Volume | |
Open interest | 4.75k |
Iovance Biotherapeutics, Inc. ( NASDAQ:IOVA ) is possibly approaching a major achievement in its business, so we would...
Iovance (IOVA) surges on the recent FDA approval for its lead pipeline drug as the first individualized, one-time cell therapy for certain patients with melanoma.
Iovance Biotherapeutics (IOVA) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.